EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieÄquivalenzstudieMultizentrische Studie

Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy

Yuanyuan Zhao, Hongxu Liu, Xiangjiao Meng iD, Zhihua Liu, Yan Yu, Yulong Zheng, Longhua Sun, Runxiang Yang, Jian Liu, Yanqiu Zhao, Lin Wu, Lei Yang und 21 weitere

New England Journal of Medicine · 22.10.2026 · 395 (16) · 1610-1620

DOI: 10.1056/nejmoa2610229 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 22.10.2026. Verfasst von Yuanyuan Zhao und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical …. Hauptthemen laut MEDLINE: Immunoconjugates, Lung Neoplasms, Small Cell Lung Carcinoma, Topotecan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Innovative Drug Research and Development National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesLung NeoplasmsSmall Cell Lung CarcinomaTopotecanAgedFemaleHumansMaleMiddle AgedProgression-Free SurvivalTopoisomerase I InhibitorsB7 AntigensAdolescentYoung AdultAdult

Substanzen

ImmunoconjugatesTopotecanTopoisomerase I InhibitorsCD276 protein, humanB7 Antigens

Autor:innen und Institutionen

  • Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou.
  • Department of Thoracic Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, China.
  • Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, China.
  • Department of Thoracic Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Department of Medical Oncology, First Affiliated Hospital, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Xiangjiao Meng, Peng Zhang, Jiuwei Cui

Förderung

  • Innovative Drug Research and Development National Science and Technology Major Project

Zitieren

APA

Zhao, Y., Liu, H., Meng, X., Liu, Z., Yu, Y., Zheng, Y., Sun, L., Yang, R., Liu, J., Zhao, Y., Wu, L., Yang, L., Zhang, Z., Li, M., Zhang, P., Zhang, Y., Zhong, H., Cui, J., Huang, Z., …, & TAISHAN-302 Investigators (2026). Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy. New England Journal of Medicine, 395(16), 1610-1620. https://doi.org/10.1056/nejmoa2610229

Vancouver

Zhao Y, Liu H, Meng X, Liu Z, Yu Y, Zheng Y, et al. Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy. New England Journal of Medicine. 2026;395(16):1610-1620. doi:10.1056/nejmoa2610229

BibTeX
@article{Zhao2026,
  author = {Zhao, Yuanyuan and Liu, Hongxu and Meng, Xiangjiao and Liu, Zhihua and Yu, Yan and Zheng, Yulong and Sun, Longhua and Yang, Runxiang and Liu, Jian and Zhao, Yanqiu and Wu, Lin and Yang, Lei and Zhang, Zhiye and Li, Mingjun and Zhang, Peng and Zhang, Yan and Zhong, Hua and Cui, Jiuwei and Huang, Zhangzhou and Yin, Yanwei and Li, Manxiang and Tong, Fan and Xue, Dan and Lv, Dongqing and Li, Xufeng and Zhang, Xian and Chin, Steve and Cai, Jiaqiang and Xue, Tongtong and Huang, Yan and Zhao, Hongyun and Zhang, Li and TAISHAN-302 Investigators, TAISHAN-302 Investigators},
  title = {Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {16},
  pages = {1610--1620},
  doi = {10.1056/nejmoa2610229}
}
Kostenlos starten →